These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2134116)

  • 21. Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsy Behav; 2006 Jun; 8(4):750-5. PubMed ID: 16647884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Event-related potentials and cognitive functions in epileptic treated patients.
    van Rijckevorsel-Harmant K; Flahaut D; Harman J; de Barsy T
    Clin Electroencephalogr; 1990 Apr; 21(2):67-73. PubMed ID: 2335041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group.
    Parnetti L; Mecocci P; Petrini A; Longo A; Buccolieri A; Senin U
    Neuropsychobiology; 1989; 22(2):97-100. PubMed ID: 2518332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
    Wesnes KA; Edgar C; Dean AD; Wroe SJ
    Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.
    Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador KJ
    Epilepsia; 2017 Dec; 58(12):2124-2132. PubMed ID: 28990169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacologic correction of learning and memory disorders induced by exposure to high-frequency electromagnetic radiation].
    Krylov IN; Iasnetsov VV; Dukhanin AS; Pal'tsev IuP
    Biull Eksp Biol Med; 1993 Mar; 115(3):260-2. PubMed ID: 8054613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of event related potentials in evaluation of subclinical cognitive dysfunction in epileptic patients.
    Ozmenek OA; Nazliel B; Leventoğlu A; Bilir E
    Acta Neurol Belg; 2008 Jun; 108(2):58-63. PubMed ID: 18795598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of oxiracetam on cerebrovascular impairment in rats.
    Kometani M; Okada M; Takemori E; Hasegawa Y; Nakao N; Inukai T
    Arzneimittelforschung; 1991 Jul; 41(7):684-9. PubMed ID: 1772453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial.
    Lim JS; Lee J; Kang Y; Park HT; Kim DE; Cha JK; Park TH; Heo JH; Lee KB; Park JM; Oh MS; Kim EG; Chang DI; Heo SH; Park MS; Park H; Yi S; Lee YB; Park KY; Lee SJ; Kim JG; Lee J; Cho KH; Rha JH; Kim YI; Lee JH; Choi JC; Oh KM; Kwon JH; Kim C; Park JH; Jung KH; Sung SM; Chung JW; Lee YS; Kim HY; Cho HJ; Park JW; Moon WJ; Bae HJ
    Contemp Clin Trials; 2023 Mar; 126():107108. PubMed ID: 36724841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subchronic hydrocortisone treatment alters auditory evoked potentials in normal subjects.
    Ashton CH; Lunn B; Marsh VR; Young AH
    Psychopharmacology (Berl); 2000 Sep; 152(1):87-92. PubMed ID: 11041320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between arousal and cognition-enhancing effects of oxiracetam.
    Cavoy A; Van Golf-Racht B; Delacour J
    Pharmacol Biochem Behav; 1994 Feb; 47(2):283-7. PubMed ID: 8146219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lamotrigine on cognition in children with epilepsy.
    Pressler RM; Binnie CD; Coleshill SG; Chorley GA; Robinson RO
    Neurology; 2006 May; 66(10):1495-9. PubMed ID: 16717207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examining factors related to accelerated long-term forgetting in epilepsy using ambulatory EEG monitoring.
    Fitzgerald Z; Thayer Z; Mohamed A; Miller LA
    Epilepsia; 2013 May; 54(5):819-27. PubMed ID: 23360077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Working memory in amyotrophic lateral sclerosis: auditory event-related potentials and neuropsychological evidence.
    Volpato C; Piccione F; Silvoni S; Cavinato M; Palmieri A; Meneghello F; Birbaumer N
    J Clin Neurophysiol; 2010 Jun; 27(3):198-206. PubMed ID: 20461012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.
    Keefe RS; Meltzer HA; Dgetluck N; Gawryl M; Koenig G; Moebius HJ; Lombardo I; Hilt DC
    Neuropsychopharmacology; 2015 Dec; 40(13):3053-60. PubMed ID: 26089183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct cognitive neurophysiologic profiles for lamotrigine and topiramate.
    Smith ME; Gevins A; McEvoy LK; Meador KJ; Ray PG; Gilliam F
    Epilepsia; 2006 Apr; 47(4):695-703. PubMed ID: 16650135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.